It's the kind of story that stops us mid-scroll and asks something painful of our attention. The trial of Lindsay Clancy—a Massachusetts mother accused of killing her three young children in January 2023—has been called "America's saddest murder trial," and as The Guardian reports, jurors last week heard from psychiatrists, medication experts, and mental health professionals about the months of care that preceded the tragedy. The defense argues that undiagnosed postpartum psychosis, compounded by a cascade of psychiatric medications, warped Clancy's sense of reality. For anyone navigating the mental health system—either for themselves or someone they love—this case lays bare questions we can't afford to leave in a courtroom.
When thirteen medications don't equal safety
What emerges from the testimony is a picture not of neglect in the traditional sense, but of something more insidious: fragmented care. The court heard that Clancy was prescribed thirteen different psychiatric medications in the months before the killings. Two psychiatrists who evaluated her described a patient reporting insomnia, emotional numbness, and suicidal thoughts—yet assessed her as "low-risk" because she had no active plan to act on those thoughts. One recommended she stop taking sertraline (Zoloft) and try fish oil and lorazepam for severe anxiety episodes. Both clinicians are now named in a medical malpractice lawsuit filed by Clancy and her former husband.
We often assume that more appointments and more prescriptions translate to more protection. But this case forces us to confront an uncomfortable reality: frequency of contact is not the same as depth of understanding. When clinicians see a patient in short windows, assess risk by narrow checklists, and rotate medications without cohesive oversight, we can end up with a treatment plan that looks thorough on paper while missing the crisis unfolding underneath.
The gap between "low-risk" and no risk at all
The psychiatrists who testified said Clancy did not exhibit signs of mania, which is one hallmark of postpartum psychosis. She expressed worry about potentially having suicidal thoughts "one day"—language that, under standard screening protocols, doesn't trigger the highest level of concern. And yet months later, she killed her three children—eight-month-old Callan, five-year-old Cora, and three-year-old Dawson—and then attempted to take her own life, jumping from a second-story window in an act that left her paralyzed from the waist down.
This is where the clinical lens must stay honest. Risk assessment tools are useful, but they are not prophecy. Postpartum conditions can escalate with terrifying speed, and the line between passive ideation and active crisis is not always visible in a fifteen-minute session. What the Clancy case exposes is a systemic vulnerability: our mental health infrastructure often depends on patients being able to articulate their own deterioration clearly enough to be heard—and on clinicians having the time and training to listen beyond the checklist.
What this asks of us
The trial continues, and its legal outcome will hinge on questions of criminal responsibility that only a jury can answer. But for those of us working to protect our own cognitive and emotional health, or supporting someone who is, the takeaway is quieter and more personal. If you or someone close to you is navigating postpartum mental health, medication changes, or a sense that something is unraveling beneath the surface—document everything. Ask clinicians direct questions about how medications interact. Request that risk assessments happen at every visit, not just the first. And if a treatment plan feels like it's being assembled in disconnected pieces, say so out loud. Anchoring ourselves in proactive advocacy within the healthcare system isn't paranoia; it's a form of care that can make the difference when professional oversight falls short.